New bladder cancer cocktail aims to keep tumors from coming back
NCT ID NCT06488222
First seen Mar 15, 2026 · Last updated May 02, 2026 · Updated 12 times
Summary
This study tests whether a combination of two chemotherapy drugs (gemcitabine and docetaxel) given directly into the bladder can prevent low-grade bladder cancer from returning. About 34 adults with intermediate-risk, non-invasive bladder cancer will receive this treatment. The goal is to see how long patients stay cancer-free and how well they tolerate the therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Florida
RECRUITINGGainesville, Florida, 32608, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.